Article

Long-term oncologic outcomes of unselected triple-negative breast cancer patients according to BRCA1/2 mutations

2023-10-12

Abstract excerpt

<title>Abstract</title> <p>Triple-negative breast cancer (TNBC) patients are more likely to have <italic>BRCA1/2</italic> mutations, with a prevalence rate of about 10–20%. Although several studies have analyzed the oncologic outcomes between <italic>BRCA1/2</italic> carriers and non-carriers, the impact on breast cancer patients is still unclear. A retrospective review was performed to determine the differences...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0e5571e7-946f-501a-b050-8efe27497800
DOI: 10.21203/rs.3.rs-3381859/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Long-term oncologic outcomes of unselected triple-negative breast cancer patients according to BRCA1/2 mutationsDOI 10.21203/rs.3.rs-3381859/v1Read

Impact of BRCA Mutation on the Survival and Risk of Contralateral Breast Cancer in Asian Breast Cancer PatientsSemantic proximity Read

Clinicopathological Features of BRCA1/2 Mutation-Positive Breast Cancer.Semantic proximity Read

Clinicopathological and Molecular Study of Triple-Negative Breast Cancer in Algerian Patients.Semantic proximity Read

The clinical feature of triple-negative breast cancer in Beijing, ChinaSemantic proximity Read

BRCA testing and Japanese original testing criteria for hereditary breast and ovarian cancer covered by public health insuranceSemantic proximity Read

Outcomes and risk of subsequent breast events in breast-conserving surgery patients with BRCA1 and BRCA2 mutation.Semantic proximity Read

Triple-Negative Breast Cancer: Molecular Particularities Still a ChallengeSemantic proximity Read

Incidence of contralateral and ipsilateral breast cancers and prognosis in BRCA1/2 pathogenic variant carriers based on the Japanese HBOC Consortium registration.Semantic proximity Read

Comparison of time-varying recurrence patterns in breast cancer patients with different molecular subtypes treated from 2008 to 2012 and from 2013 to 2016: a single-center retrospective studySemantic proximity Read

BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients.Semantic proximity Read

Impact of breast surgical procedure on survival in BRCA mutated patients with invasive breast cancer: Mastectomy versus conservative treatment.Semantic proximity Read

New Biomarkers and Treatment Advances in Triple-Negative Breast CancerSemantic proximity Read